Journal of Clinical Medicine Review Staphylococcus aureus Keratitis: Incidence, Pathophysiology, Risk Factors and Novel Strategies for Treatment Jason W. Lee 1, Tobi Somerville 2,3, Stephen B. Kaye 2,3 and Vito Romano 2,3,* 1 School of Medicine, University of Liverpool, Liverpool L69 3GE, UK;
[email protected] 2 Department of Eye and Vision Science, University of Liverpool, Liverpool L7 8TX, UK;
[email protected] (T.S.);
[email protected] (S.B.K.) 3 St Paul’s Eye Unit, Royal Liverpool University Hospital, Liverpool L7 8XP, UK * Correspondence:
[email protected] Abstract: Bacterial keratitis is a devastating condition that can rapidly progress to serious complica- tions if not treated promptly. Certain causative microorganisms such as Staphylococcus aureus and Pseudomonas aeruginosa are notorious for their resistance to antibiotics. Resistant bacterial keratitis results in poorer outcomes such as scarring and the need for surgical intervention. Thorough un- derstanding of the causative pathogen and its virulence factors is vital for the discovery of novel treatments to avoid further antibiotic resistance. While much has been previously reported on P. aeruginosa, S. aureus has been less extensively studied. This review aims to give a brief overview of S. aureus epidemiology, pathophysiology and clinical characteristics as well as summarise the current evidence for potential novel therapies. Keywords: keratitis; microbial keratitis; Staphylococcus aureus; pathophysiology; novel therapy; therapeutics; treatment Citation: Lee, J.W.; Somerville, T.; Kaye, S.B.; Romano, V. Staphylococcus aureus Keratitis: Incidence, Pathophysiology, Risk Factors and 1. Introduction Novel Strategies for Treatment. J. Clin. Keratitis is a sight-threatening disease [1], with the majority of cases attributed to Med.